Healthcare Services

Interventional Oncology Market Outlook Through 2030 With Analysis Of Industry Trends And Developments

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Interventional Oncology Market Progress Through 2030?

The interventional oncology market size has experienced robust growth in recent years. It is projected to expand from $2.72 billion in 2025 to $2.96 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. This historical growth can be attributed to several factors, including the increasing global incidence of cancer, the expansion of interventional radiology services, a rising demand for minimally invasive procedures, improved accessibility to imaging-guided devices, and augmented investments in hospital oncology.

The interventional oncology market is anticipated to experience substantial expansion over the upcoming years. By 2030, its valuation is projected to reach $4.14 billion, expanding at a compound annual growth rate (CAGR) of 8.7%. This projected growth is driven by factors such as the greater acceptance of AI-powered imaging guidance, the growing need for outpatient cancer therapies, the broadening of personalized oncology strategies, increasing capital allocation into sophisticated ablation technologies, and an amplified emphasis on minimizing patient recovery periods. Key developments expected during this outlook period encompass a wider uptake of image-guided approaches for cancer treatment, an increase in the application of minimally invasive ablation methods, deeper incorporation of advanced imaging techniques, the proliferation of targeted tumor treatment methodologies, and a heightened emphasis on precision oncology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27318&type=smp

What Major Growth Factors Are Impacting The Interventional Oncology Market?

The expanding occurrence of cancer is projected to fuel the advancement of the interventional oncology market in the future. Cancer prevalence denotes the aggregate count of individuals, encompassing both recent and prior diagnoses, who are living with a history of the disease at a given moment. This rise in cancer prevalence stems from lifestyle factors like inadequate nutrition, tobacco use, alcohol intake, and exposure to environmental contaminants, which heighten the likelihood of developing diverse cancers. Interventional oncology assists in cancer therapy by offering targeted, minimally invasive treatments that directly address tumors. This approach enhances patient results by minimizing harm to healthy cells and providing quicker recuperation periods relative to conventional methods. As an illustration, in February 2024, the World Health Organization, an international organization based in Switzerland focused on global health policy and public health initiatives, projected more than 35 million new cancer cases in 2050, representing a 77% surge from the approximate 20 million cases recorded in 2022. Consequently, the rising incidence of cancer is propelling the expansion of the interventional oncology market.

What Are The Core Segment Classifications In The Interventional Oncology Market?

The interventional oncology market covered in this report is segmented –

1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices

2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided

3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care

4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer

5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions

Subsegments:

1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems

3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices

Which Trends Are Guiding The Development Of The Interventional Oncology Market?

Major companies operating in the interventional oncology market are concentrating on developing sophisticated products, such as microcatheter-based embolization systems, with the aim of delivering precise, targeted cancer therapy while minimizing damage to surrounding healthy tissue. These microcatheter-based embolization systems are medical devices that use tiny, flexible catheters to accurately deliver embolic agents into blood vessels to block or reduce blood flow, typically for treating tumors, vascular malformations, or bleeding. For instance, in March 2025, Terumo Corporation, a Japan-based medical device company, launched the Occlusafe balloon occlusion catheter. This device is based on its advanced Balloon-TACE (B-TACE) therapy for the treatment of liver cancer, particularly hepatocellular carcinoma (HCC). This specialized microcatheter leverages the pressure gradient effect to redirect blood flow and access the microcirculation, enabling higher concentrations of therapeutic agents at the tumor site while minimizing off-target embolization. This targeted approach aims to improve clinical outcomes in difficult-to-treat liver cancer cases by enhancing drug delivery precision and offering improved visualization during procedures.

Who Are The Prominent Players Across The Interventional Oncology Market?

Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet SA, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited, Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Medtronic plc, Koninklijke Philips NV, Cook Medical Incorporated

Access The Complete Interventional Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-global-market-report

Which Region Leads The Interventional Oncology Market By Size?

North America was the largest region in the interventional oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Interventional Oncology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=27318&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Market 2026, By The Business Research Company

Black Lung Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

Idiopathic Pulmonary Fibrosis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/idiopathic-pulmonary-fibrosis-global-market-report

Artificial Lung Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795